🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are urged to message these accounts privately for source information, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of rapid British shipping. Sellers market the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could result in users administering products of unknown origin.

Some professionals stated the popularity for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Elimination

According to the social media company, the service has taken down violative material and banned related keywords and search suggestions. The company stated it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with images of weight loss, glowing testimonials and detailed guides for mixing or injecting at residence.

Within minutes of entering one group, a vendor posted contact information, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Details and Pricing

Within these groups, posts show black plastic packages with postal service labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially serious health risks”.